{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:05:13Z","timestamp":1790521513302,"version":"4.1.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T00:00:00Z","timestamp":1583798400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T00:00:00Z","timestamp":1583798400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Scientific Fund Willy Gepts-Belgium"},{"name":"Center for Alternatives to Animal Testing at Johns Hopkins University-USA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00204-020-02691-9","type":"journal-article","created":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T05:04:24Z","timestamp":1583816664000},"page":"1151-1172","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Robustness testing and optimization of an adverse outcome pathway on cholestatic liver injury"],"prefix":"10.1007","volume":"94","author":[{"given":"Eva","family":"Gijbels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e2nia","family":"Vilas\u2010Boas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Annaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Vanhaecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Devisscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5115-8893","authenticated-orcid":false,"given":"Mathieu","family":"Vinken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,10]]},"reference":[{"key":"2691_CR1","doi-asserted-by":"crossref","first-page":"e2390","DOI":"10.1038\/cddis.2016.280","volume":"7","author":"MB Afonso","year":"2016","unstructured":"Afonso MB, Rodrigues PM, Sim\u00e3o AL et al (2016) Activation of necroptosis in human and experimental cholestasis. Cell Death Dis 7:e2390","journal-title":"Cell Death Dis"},{"key":"2691_CR3","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/etc.34","volume":"29","author":"GT Ankley","year":"2010","unstructured":"Ankley GT, Bennett RS, Erickson RJ et al (2010) Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ Toxicol Chem 29:730\u2013741","journal-title":"Environ Toxicol Chem"},{"key":"2691_CR4","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1002\/hep.26160","volume":"57","author":"S Anth\u00e9rieu","year":"2013","unstructured":"Anth\u00e9rieu S, Bachour-El Azzi P, Dumont J et al (2013) Oxidative stress plays a major role in chlorpromazine-induced cholestasis in human HepaRG cells. Hepatology 57:1518\u20131529","journal-title":"Hepatology"},{"key":"2691_CR5","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.2741\/e539","volume":"4","author":"A Arduini","year":"2012","unstructured":"Arduini A, Serviddio G, Tormos AM et al (2012) Mitochondrial dysfunction in cholestatic liver diseases. Front Biosci 4:2233\u20132252","journal-title":"Front Biosci"},{"key":"2691_CR6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/toxsci\/kfv041","volume":"145","author":"P Bachour-El Azzi","year":"2015","unstructured":"Bachour-El Azzi P, Sharanek A, Burban A et al (2015) Comparative localization and functional activity of the main hepatobiliary transporters in HepaRG cells and primary human hepatocytes. Toxicol Sci 145:157\u2013168","journal-title":"Toxicol Sci"},{"key":"2691_CR7","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1177\/1535370214531872","volume":"239","author":"SS Bale","year":"2014","unstructured":"Bale SS, Vernetti L, Senutovitch N et al (2014) In vitro platforms for evaluating liver toxicity. Exp Biol Med 239:1180\u20131191","journal-title":"Exp Biol Med"},{"key":"2691_CR8","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jhep.2010.11.006","volume":"54","author":"K Begriche","year":"2011","unstructured":"Begriche K, Massart J, Robin MA et al (2011) Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver. J Hepatol 54:773\u2013794","journal-title":"J Hepatol"},{"key":"2691_CR9","first-page":"58","volume":"1867","author":"TA Bhat","year":"2017","unstructured":"Bhat TA, Chaudhary AK, Kumar S et al (2017) Endoplasmic reticulum-mediated unfolded protein response and mitochondrial apoptosis in cancer. Biochim Biophis Acta 1867:58\u201366","journal-title":"Biochim Biophis Acta"},{"issue":"3","key":"2691_CR71","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1089\/aid.2012.0233","volume":"29","author":"E Bissio","year":"2013","unstructured":"Bissio E, Lopardo GD (2013) Incidence of hyperbilirubinemia and jaundice due to atazanavir in a cohort of hispanic patients. AIDS Res Hum Retroviruses 29(3):415\u2013417","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2691_CR10","first-page":"930","volume":"272","author":"R Botla","year":"1995","unstructured":"Botla R, Spivey JR, Aguilar H et al (1995) Ursodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: a mechanism of UDCA cytoprotection. J Pharmacol Exp Ther 272:930\u2013938","journal-title":"J Pharmacol Exp Ther"},{"key":"2691_CR11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.freeradbiomed.2017.11.017","volume":"115","author":"A Burban","year":"2018","unstructured":"Burban A, Sharanek A, Guguen-Guillouzo C et al (2018) Endoplasmic reticulum stress precedes oxidative stress in antibiotic-induced cholestasis and cytotoxicity in human hepatocytes. Free Radic Biol Med 115:166\u2013178","journal-title":"Free Radic Biol Med"},{"key":"2691_CR12","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/toxsci\/kfx062","volume":"157","author":"MG Burbank","year":"2017","unstructured":"Burbank MG, Sharanek A, Burban A et al (2017) Mechanistic insights in cytotoxic and cholestatic potential of the endothelial receptor antagonists using HepaRG cells. Toxicol Sci 157:451\u2013464","journal-title":"Toxicol Sci"},{"key":"2691_CR13","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.taap.2013.10.032","volume":"274","author":"S Chatterjee","year":"2014","unstructured":"Chatterjee S, Richert L, Augustijns P et al (2014) Hepatocyte-based in vitro model for assessment of drug-induced cholestasis. Toxicol Appl Pharmacol 274:124\u2013136","journal-title":"Toxicol Appl Pharmacol"},{"key":"2691_CR14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0030-1253228","volume":"30","author":"BL Copple","year":"2010","unstructured":"Copple BL, Jaeschke H, Klaassen CD (2010) Oxidative stress and the pathogenesis of cholestasis. Semin Liver Dis 30:195\u2013204","journal-title":"Semin Liver Dis"},{"key":"2691_CR15","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1124\/dmd.111.040758","volume":"40","author":"S Dawson","year":"2012","unstructured":"Dawson S, Stahl S, Paul N et al (2012) In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans. Drug Metab Dispos 40:130\u2013138","journal-title":"Drug Metab Dispos"},{"key":"2691_CR16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-1-4939-9420-5_2","volume":"1981","author":"D Dewaele","year":"2019","unstructured":"Dewaele D, Annaert P, Hoeben E (2019) LC-MS\/MS analysis of bile acids in in vitro samples. Methods Mol Biol 1981:15\u201323","journal-title":"Methods Mol Biol"},{"key":"2691_CR17","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1007\/s00204-016-1845-1","volume":"90","author":"S Dragovic","year":"2016","unstructured":"Dragovic S, Vermeulen NPE, Gerets HH et al (2016) Evidence-based selection of training compounds for use in the mechanism-based integrated prediction of drug-induced liver injury in man. Arch Toxicol 90:2979\u20133003","journal-title":"Arch Toxicol"},{"key":"2691_CR18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/2045-3701-4-47","volume":"4","author":"L Gao","year":"2014","unstructured":"Gao L, Lv G, Guo X et al (2014) Activation of autophagy protects against cholestasis-induced hepatic injury. Cell Biosci 4:47","journal-title":"Cell Biosci"},{"key":"2691_CR19","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s00204-019-02437-2","volume":"93","author":"E Gijbels","year":"2019","unstructured":"Gijbels E, Vilas-Boas V, Deferm N et al (2019) Mechanisms and in vitro models of drug-induced cholestasis. Arch Toxicol 93:1169\u20131186","journal-title":"Arch Toxicol"},{"issue":"7","key":"2691_CR68","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1053\/j.gastro.2015.02.050","volume":"148","author":"DS Goldberg","year":"2015","unstructured":"Goldberg DS, Forde KA, Carbonari DM, Lewis JD, Leidl KBF, Reddy KR, Haynes K, Roy J, Sha D, Marks AR, Schneider JL, Strom BL, Corley DA, Lo Re V (2015) Population-representative incidence of drug-induced acute liver failure based on an analysis of an integrated health care system. Gastroenterology 148(7):1353\u20131361.e3","journal-title":"Gastroenterology"},{"key":"2691_CR20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0005-2728(98)00111-X","volume":"1366","author":"GJ Gores","year":"1998","unstructured":"Gores GJ, Miyoshi H, Botla R et al (1998) Induction of the mitochondrial permeability transition as a mechanism of liver injury during cholestasis: a potential role for mitochondrial proteases. Biochim Biophys Acta 1366:167\u2013175","journal-title":"Biochim Biophys Acta"},{"key":"2691_CR21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cld.2012.12.001","volume":"17","author":"E Halilbasic","year":"2013","unstructured":"Halilbasic E, Baghdasaryan A, Trauner M (2013) Nuclear receptors as drug targets in cholestatic liver diseases. Clin Liver Dis 17:161\u2013189","journal-title":"Clin Liver Dis"},{"key":"2691_CR22","doi-asserted-by":"crossref","first-page":"35434","DOI":"10.1038\/srep35434","volume":"6","author":"DFG Hendriks","year":"2016","unstructured":"Hendriks DFG, Puigvert LF, Messner S et al (2016) Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability. Sci Rep 6:35434","journal-title":"Sci Rep"},{"key":"2691_CR23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jcmgh.2016.11.006","volume":"3","author":"AS Henkel","year":"2017","unstructured":"Henkel AS, LeCuper B, Olivares S et al (2017) Endoplasmic reticulum stress regulated hepatic bile acid metabolism in mice. Cell Mol Gastroenterol Hepatol 3:261\u2013271","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2691_CR24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jchromb.2012.05.015","volume":"899","author":"L Humbert","year":"2012","unstructured":"Humbert L, Maubert MA, Wolf C et al (2012) Bile acid profiling in human biological samples: comparison of extraction procedures and application to normal and cholestatic patients. J Chromatogr B 899:135\u2013145","journal-title":"J Chromatogr B"},{"key":"2691_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-7677-5_22","author":"SC Jones","year":"2018","unstructured":"Jones SC, Kortepeter C, Brinker AD (2018) Postmarketing surveillance of drug-induced liver injury. Drug-induced liver toxicity. Methods Pharmacol Toxicol. https:\/\/doi.org\/10.1007\/978-1-4939-7677-5_22","journal-title":"Methods Pharmacol Toxicol"},{"key":"2691_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-642-56553-3_1","volume":"161","author":"Z Kmi\u00e9c","year":"2001","unstructured":"Kmi\u00e9c Z (2001) Cooperation of liver cells in health and disease. Adv Anat Embryol Cell Biol 161:1\u2013151","journal-title":"Adv Anat Embryol Cell Biol"},{"key":"2691_CR28","doi-asserted-by":"crossref","first-page":"86","DOI":"10.14218\/JCTH.2018.00042","volume":"7","author":"TO Kolari\u0107","year":"2019","unstructured":"Kolari\u0107 TO, Nin\u010devi\u0107 V, Smoli\u0107 R et al (2019) Mechanisms of hepatic cholestatic drug injury. J Clin Transl Hepatol 7:86\u201392","journal-title":"J Clin Transl Hepatol"},{"key":"2691_CR29","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/toxsci\/kfj095","volume":"90","author":"SE Kostrubsky","year":"2006","unstructured":"Kostrubsky SE, Strom SC, Kalgutkar AS et al (2006) Inhibition of hepatobiliary transport as a predictive method for clinical hepatotoxicity of nefazodone. Toxicol Sci 90:451\u2013459","journal-title":"Toxicol Sci"},{"key":"2691_CR30","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00228-010-0862-x","volume":"66","author":"HG Laverty","year":"2010","unstructured":"Laverty HG, Antoine DJ, Benson C et al (2010) The potential of cytokines as safety biomarkers for drug-induced liver injury. Eur J Clin Pharmacol 66:961\u2013976","journal-title":"Eur J Clin Pharmacol"},{"key":"2691_CR31","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cld.2013.07.001","volume":"17","author":"WM Lee","year":"2013","unstructured":"Lee WM (2013) Drug-induced acute liver failure. Clin Liver Dis 17:575\u2013586","journal-title":"Clin Liver Dis"},{"key":"2691_CR32","doi-asserted-by":"crossref","first-page":"e87548","DOI":"10.1371\/journal.pone.0087548","volume":"9","author":"EI Lepist","year":"2014","unstructured":"Lepist EI, Gillies H, Smith W et al (2014) Evaluation of the endothelin receptor antagonists ambrisentan, bosentan, macitentan, and sitaxsentan as hepatobiliary transporter inhibitors and substrates in sandwich- cultured human hepatocytes. PLoS ONE 9:e87548","journal-title":"PLoS ONE"},{"key":"2691_CR33","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/hep.29540","volume":"67","author":"R Liu","year":"2018","unstructured":"Liu R, Li X, Huang Z et al (2018) C\/EBP homologous protein-induced loss of intestinal epithelial stemness contributes to bile duct ligation-induced cholestatic liver injury in mice. Hepatology 67:1441\u20131457","journal-title":"Hepatology"},{"key":"2691_CR35","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jhep.2010.11.005","volume":"54","author":"H Malhi","year":"2011","unstructured":"Malhi H, Kaufman RJ (2011) Endoplasmic reticulum stress in liver disease. J Hepatol 54:795\u2013809","journal-title":"J Hepatol"},{"key":"2691_CR36","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/hep.24132","volume":"53","author":"MR McGill","year":"2011","unstructured":"McGill MR, Yan HM, Ramachandran A et al (2011) HepaRG cells: a human model to study mechanisms of acetaminophen hepatotoxicity. Hepatology 53:974\u2013982","journal-title":"Hepatology"},{"key":"2691_CR37","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/toxsci\/kft246","volume":"137","author":"S Manley","year":"2014","unstructured":"Manley S, Ni HM, Kong B et al (2014) Suppression of autophagic flux by bile acids in hepatocytes. Toxicol Sci 137:478\u2013490","journal-title":"Toxicol Sci"},{"key":"2691_CR38","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.bbadis.2017.06.027","volume":"1864","author":"V Mariotti","year":"2017","unstructured":"Mariotti V, Strazzabosco M, Fabris L et al (2017) Animal models of biliary injury and altered bile acid metabolism. Biochim Biophys Acta 1864:1254\u20131261","journal-title":"Biochim Biophys Acta"},{"key":"2691_CR39","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/toxsci\/kfq269","volume":"118","author":"RE Morgan","year":"2010","unstructured":"Morgan RE, Trauner M, van Staden CJ et al (2010) Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicol Sci 118:485\u2013500","journal-title":"Toxicol Sci"},{"key":"2691_CR40","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.3748\/wjg.v20.i30.10279","volume":"20","author":"KD Nguyen","year":"2014","unstructured":"Nguyen KD, Sundaram V, Ayoub WS (2014) Atypical causes of cholestasis. World J Gastroenterol 20:9418\u20139426","journal-title":"World J Gastroenterol"},{"key":"2691_CR41","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.1113\/JP271124","volume":"593","author":"F Noor","year":"2015","unstructured":"Noor F (2015) A shift in paradigm towards human biology-based systems for cholestatic-liver diseases. J Physiol 593:5043\u20135055","journal-title":"J Physiol"},{"key":"2691_CR42","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.tiv.2016.03.008","volume":"34","author":"M Oorts","year":"2016","unstructured":"Oorts M, Baze A, Bachellier P et al (2016) Drug-induced cholestasis risk assessment in sandwich-cultured human hepatocytes. Toxicol In Vitro 34:179\u2013196","journal-title":"Toxicol In Vitro"},{"key":"2691_CR43","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1053\/j.gastro.2004.01.002","volume":"126","author":"R Parent","year":"2004","unstructured":"Parent R, Marion MJ, Furio L et al (2004) Origin and characterization of a human bipotent liver progenitor cell line. Gastroenterology 126:1147\u20131156","journal-title":"Gastroenterology"},{"issue":"8","key":"2691_CR69","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1248\/bpb.b18-00028","volume":"41","author":"X Qu","year":"2018","unstructured":"Qu X, Zhang Y, Zhang S, Zhai J, Gao H, Tao L, Song Y (2018) Dysregulation of BSEP and MRP2 may play an important role in isoniazid-induced liver injury via the SIRT1\/FXR pathway in rats and HepG2 cells. Biol Pharm Bull 41(8):1211\u20131218","journal-title":"Biol Pharm Bull"},{"key":"2691_CR44","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/cid\/cis620","volume":"55","author":"S Rakotondravelo","year":"2012","unstructured":"Rakotondravelo S, Poinsignon Y, Borsa-Lebas F et al (2012) Complicated atazanavir-associated cholelithiasis: a report of 14 cases. Clin Infect Dis 55:1270\u20131272","journal-title":"Clin Infect Dis"},{"key":"2691_CR45","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1124\/dmd.116.074179","volume":"45","author":"J Riede","year":"2017","unstructured":"Riede J, Poller B, Huwyler J et al (2017) Assessing the risk of drug-induced cholestasis using unbound intrahepatic concentrations. Drug Metab Dispos 45:523\u2013531","journal-title":"Drug Metab Dispos"},{"key":"2691_CR46","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1007\/s00204-018-2214-z","volume":"92","author":"RM Rodrigues","year":"2018","unstructured":"Rodrigues RM, Kollipara L, Chaudhari U et al (2018) Omics-based responses induced by bosentan in human hepatoma HepaRG cell cultures. Arch Toxicol 92:1939\u20131952","journal-title":"Arch Toxicol"},{"key":"2691_CR47","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/toxsci\/71.2.276","volume":"71","author":"ID Roman","year":"2003","unstructured":"Roman ID, Fernandez-Moreno MD, Fueyo JA et al (2003) Cyclosporin A induced internalization of the bile salt export pump in isolated rat hepatocyte couplets. Toxicol Sci 71:276\u2013281","journal-title":"Toxicol Sci"},{"key":"2691_CR48","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/hep.20246","volume":"39","author":"MH Schoemaker","year":"2004","unstructured":"Schoemaker MH, Conde de la Rosa L, Buist-Homan M et al (2004) Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways. Hepatology 39:1563\u20131573","journal-title":"Hepatology"},{"key":"2691_CR49","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1073\/pnas.1222878110","volume":"110","author":"J Seok","year":"2013","unstructured":"Seok J, Warren HS, Cuenca AG et al (2013) Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci USA 110:3507\u20133512","journal-title":"Proc Natl Acad Sci USA"},{"key":"2691_CR50","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/toxsci\/kfu122","volume":"141","author":"A Sharanek","year":"2014","unstructured":"Sharanek A, Bachour-El Azzi P, Al-Attrache H et al (2014) Different dose-dependent mechanisms are involved in early cyclosporine-A induced cholestatic effects in HepaRG cells. Toxicol Sci 141:244\u2013253","journal-title":"Toxicol Sci"},{"key":"2691_CR51","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/toxsci\/kfv155","volume":"147","author":"A Sharanek","year":"2015","unstructured":"Sharanek A, Burban A, Humbert L et al (2015) Cellular accumulation and toxic effects of bile acids in cyclosporine A-treated HepaRG hepatocytes. Toxicol Sci 147:573\u2013587","journal-title":"Toxicol Sci"},{"key":"2691_CR52","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1124\/dmd.117.077420","volume":"45","author":"A Sharanek","year":"2017","unstructured":"Sharanek A, Burban A, Humbert L et al (2017) Progressive and preferential cellular accumulation of hydrophobic bile acids induced by cholestatic drugs is associated with inhibition of their amidation and sulfatation. Drug Metab Dispos 45:1292\u20131303","journal-title":"Drug Metab Dispos"},{"key":"2691_CR55","first-page":"52438","volume":"96","author":"CG Tag","year":"2015","unstructured":"Tag CG, Sauer-Lehnen S, Weiskirchen S et al (2015) Bile duct ligation in mice: induction of inflammatory liver injury and fibrosis by obstructive cholestasis. J Vis Exp 96:52438","journal-title":"J Vis Exp"},{"key":"2691_CR56","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1515\/CCLM.2003.247","volume":"41","author":"D Tagliacozzi","year":"2003","unstructured":"Tagliacozzi D, Mozzi AF, Casetta B et al (2003) Quantitative analysis of bile acids in human plasma by liquid chromatography-electrospray tandem mass spectrometry: a simple and rapid one-step method. Clin Chem Lab Med 41:1633\u20131641","journal-title":"Clin Chem Lab Med"},{"key":"2691_CR57","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-1-4939-9420-5_15","volume":"1981","author":"S Van Campenhout","year":"2019","unstructured":"Van Campenhout S, Van Vlierberghe H, Devisscher L (2019) Common bile duct ligation as model for secondary biliary cirrhosis. Methods Mol Biol 1981:237\u2013247","journal-title":"Methods Mol Biol"},{"key":"2691_CR58","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.tiv.2014.12.016","volume":"29","author":"WF Van den Hof","year":"2015","unstructured":"Van den Hof WF, Ruiz-Aracama A, Van Summeren A et al (2015) Integrating multiple omics to unravel mechanisms of cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro 29:489\u2013501","journal-title":"Toxicol In Vitro"},{"issue":"3","key":"2691_CR70","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00204-016-1778-8","volume":"91","author":"S Vatakuti","year":"2017","unstructured":"Vatakuti S, Olinga P, Pennings JLA, Groothuis GMM (2017) Validation of precision-cut liver slices to study drug-induced cholestasis: a transcriptomics approach. Arch Toxicol 91(3):1401\u20131412","journal-title":"Arch Toxicol"},{"key":"2691_CR60","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/toxsci\/kfu199","volume":"142","author":"DL Villeneuve","year":"2014","unstructured":"Villeneuve DL, Crump D, Garcia-Reyero N et al (2014) Adverse outcome pathway (AOP) development I: strategies and principles. Toxicol Sci 142:312\u2013320","journal-title":"Toxicol Sci"},{"key":"2691_CR61","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/toxsci\/kft177","volume":"136","author":"M Vinken","year":"2013","unstructured":"Vinken M, Landesmann B, Goumenou M et al (2013) Development of an adverse outcome pathway from drug-mediated bile salt export pump inhibition to cholestatic liver injury. Toxicol Sci 136:97\u2013106","journal-title":"Toxicol Sci"},{"key":"2691_CR62","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.3748\/wjg.v18.i36.4985","volume":"18","author":"BL Woolbright","year":"2012","unstructured":"Woolbright BL, Jaeschke H (2012) Novel insight into mechanisms of cholestatic liver injury. World J Gastroenterol 18:4985\u20134993","journal-title":"World J Gastroenterol"},{"key":"2691_CR63","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1042\/bj3540591","volume":"354","author":"S Yasumiba","year":"2001","unstructured":"Yasumiba S, Tazuma S, Ochi H et al (2001) Cyclosporin A reduces canalicular membrane fluidity and regulates transporter function in rats. Biochem J 354:591\u2013596","journal-title":"Biochem J"},{"key":"2691_CR64","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1124\/dmd.105.005447","volume":"33","author":"D Zhang","year":"2005","unstructured":"Zhang D, Chango TJ, Everett DW et al (2005) In vitro inhibition of UDP glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation. Drug Metab Dispos 33:1729\u20131739","journal-title":"Drug Metab Dispos"},{"key":"2691_CR65","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cbi.2016.03.019","volume":"255","author":"J Zhang","year":"2016","unstructured":"Zhang J, Kan H, Cai L et al (2016) Inhibition of bile salt transport by drugs associated with liver injury in primary hepatocytes from human, monkey, dog, rat and mouse. Chem Biol Interact 255:45\u201354","journal-title":"Chem Biol Interact"},{"key":"2691_CR66","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1021\/mp060010s","volume":"3","author":"G Zollner","year":"2006","unstructured":"Zollner G, Marschall HU, Wagner M et al (2006) Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations. Mol Pharm 3:231\u2013251","journal-title":"Mol Pharm"},{"key":"2691_CR67","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s10354-006-0312-7","volume":"156","author":"G Zollner","year":"2006","unstructured":"Zollner G, Trauner M (2006) Molecular mechanisms of cholestasis. Wien Med Wochenschr 156:380\u2013385","journal-title":"Wien Med Wochenschr"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-020-02691-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00204-020-02691-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-020-02691-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:14:11Z","timestamp":1615335251000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00204-020-02691-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,10]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["2691"],"URL":"https:\/\/doi.org\/10.1007\/s00204-020-02691-9","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,10]]},"assertion":[{"value":"18 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}